Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Lara Goldstein

558 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
9 minute read
  • Cannabis
  • FDA
  • Guidance
  • Legal
  • Management
  • Markets
  • News
  • Psychedelics
  • Small Cap

Psychedelics And Treatment-Resistant Depression: COMPASS Pathways Replies To Comments

By Lara Goldstein
December 9, 10:23 AM
(Part four of a four-part series) See previous stories: 

CMPS

Read More
2 minute read
  • Cannabis
  • Guidance
  • Legal
  • Management
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Psychedelic Therapy Boosted By 3D Movement Data? This Company Is Aiming To Patent The Combination

By Lara Goldstein
December 7, 2:47 PM
Canadian magic mushrooms and truffles producer Red Light Holland Corp.

TRUFF

Read More
2 minute read
  • Cannabis
  • General
  • Health Care
  • Markets
  • News
  • Offerings
  • Psychedelics
  • Tech
  • Top Stories

Free Ketamine Therapy? Laid Off Tech Workers Can Request Month Of ‘Freedom’ Program

By Lara Goldstein
December 7, 2:39 PM
A considerable number of employees have been fired from their jobs at big tech firms.

AMZN

Read More
1 minute read
  • Cannabis
  • General
  • Health Care
  • Legal
  • Management
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Psychedelics Production Methods Expect Further IP Protection With 4 New Patents

By Lara Goldstein
December 7, 2:02 PM
Biotech company PsyBio Therapeutics Corp. (OTCQB: PSYBF) has filed four new U.S. Patent Cooperation Treaty (PCT) applications aiming to convert five provisional patent applications. 

PSYBF

Read More
4 minute read
  • Cannabis
  • Legal
  • Markets
  • News
  • Psychedelics

Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal’s Decrim Project

By Lara Goldstein
December 6, 3:20 PM
Psychedelic Research & Fed Funding By The National Institute Of Mental Health The National Institute of Mental Health (NIMH) named the types of psychedelics studies to which it would grant funds and further guidance for pre-clinical research and studies with young participants.

AWKNF

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Europe To Have Expanded Access To Psychedelic-Assisted Therapy With New Norway Clinic

By Lara Goldstein
December 3, 3:00 PM
Psychedelics biotech Awakn Life Sciences Corp.

AWKNF

Read More
4 minute read
  • Cannabis
  • Legal
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Small Cap

Psyched: Full-Dose & Microdosing LSD Studies, Research Scope For Fed Funding, Consumption Sites And More

By Lara Goldstein
November 29, 1:15 PM
LSD Research Ramps Up: Full-Dose & Microdosing For Alzheimer's Studies Led By Beckley Foundation Coming Soon

AWKNF

Read More
2 minute read
  • Cannabis
  • General
  • Global
  • Health Care
  • Management
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Top Stories

A Leading Ketamine Treatment Clinic For Alcoholism Is Expanding: Here’s The Latest

By Lara Goldstein
November 23, 2:27 PM
A psychedelics R&D biotech company, known for providing novel treatments for addictions, is opening a new ketamine clinic. 

AWKNF

Read More
6 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Psyched: Musk’s Empathy Tweets, Psychedelics In Congress, Oregon’s Opt-Outs, MAPS’ MDMA Trial And More

By Lara Goldstein
November 21, 8:13 PM
Elon Musk Joins Twitter Conversation Around Psychedelics: A Debate On Empathy

AGNPF

Read More
3 minute read
  • Cannabis
  • Legal
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Oregon Psychedelics Companies Set The Stage For Future Regulations Of Natural Medicine Centers

By Lara Goldstein
November 21, 4:59 PM
Silo Wellness (OTCQB: SILFF) aims to establish a psilocybin center retreat in the New Frontier Ranch in Jackson County seems closer to becoming a reality.

SILFF

Posts pagination

Previous 1 … 40 41 42 … 56 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service